Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?
Evora
P R
PR
D000707:Anaphylaxis / Q000188:drug therapy* / Q000209:etiology*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D006801:Humans; D007022:Hypotension / Q000188:drug therapy* / Q000209:etiology*; D008751:Methylene Blue / Q000627:therapeutic use*; D014655:Vascular Resistance
D008751:Methylene Blue